Mechanisms of Innate Neuroprotection
As clinical trials of pharmacological neuroprotective strategies in stroke have been disappointing, attention has turned to the brain's own endogenous strategies for neuroprotection. Two endogenous mechanisms have been recently characterized, ischemic preconditioning and ischemic postconditioni...
Saved in:
Superior document: | Frontiers Research Topics |
---|---|
: | |
Year of Publication: | 2016 |
Language: | English |
Series: | Frontiers Research Topics
|
Physical Description: | 1 electronic resource (138 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993546800604498 |
---|---|
ctrlnum |
(CKB)3800000000216258 (oapen)https://directory.doabooks.org/handle/20.500.12854/52944 (EXLCZ)993800000000216258 |
collection |
bib_alma |
record_format |
marc |
spelling |
Giuseppe Pignataro auth Mechanisms of Innate Neuroprotection Frontiers Media SA 2016 1 electronic resource (138 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Frontiers Research Topics As clinical trials of pharmacological neuroprotective strategies in stroke have been disappointing, attention has turned to the brain's own endogenous strategies for neuroprotection. Two endogenous mechanisms have been recently characterized, ischemic preconditioning and ischemic postconditioning. In the present topic newly characterized mechanisms involved in preconditioning- and postconditioning- neuroprotection will be discussed. The understanding of the mechanisms involved in the neuroprotective pathways induced by preconditioning and postconditioning will be clinically relevant for identifying new druggable target for neurodegenerative disorder therapy. Furthermore, the importance of these neuroprotective strategies resides in that it might be easily translatable into clinical practice. Therefore, the data presented here will highlight the capacity of ischemic preconditioning and postconditioning to be of benefit to humans. English Neuroprotection postconditioning NCX Stroke seizure miRNA Alzheimer preconditioning 2-88919-929-0 |
language |
English |
format |
eBook |
author |
Giuseppe Pignataro |
spellingShingle |
Giuseppe Pignataro Mechanisms of Innate Neuroprotection Frontiers Research Topics |
author_facet |
Giuseppe Pignataro |
author_variant |
g p gp |
author_sort |
Giuseppe Pignataro |
title |
Mechanisms of Innate Neuroprotection |
title_full |
Mechanisms of Innate Neuroprotection |
title_fullStr |
Mechanisms of Innate Neuroprotection |
title_full_unstemmed |
Mechanisms of Innate Neuroprotection |
title_auth |
Mechanisms of Innate Neuroprotection |
title_new |
Mechanisms of Innate Neuroprotection |
title_sort |
mechanisms of innate neuroprotection |
series |
Frontiers Research Topics |
series2 |
Frontiers Research Topics |
publisher |
Frontiers Media SA |
publishDate |
2016 |
physical |
1 electronic resource (138 p.) |
isbn |
2-88919-929-0 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT giuseppepignataro mechanismsofinnateneuroprotection |
status_str |
n |
ids_txt_mv |
(CKB)3800000000216258 (oapen)https://directory.doabooks.org/handle/20.500.12854/52944 (EXLCZ)993800000000216258 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Frontiers Research Topics |
is_hierarchy_title |
Mechanisms of Innate Neuroprotection |
container_title |
Frontiers Research Topics |
_version_ |
1787551980232638466 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01929nam-a2200361z--4500</leader><controlfield tag="001">993546800604498</controlfield><controlfield tag="005">20231214133359.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2016 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3800000000216258</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/52944</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993800000000216258</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Giuseppe Pignataro</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Mechanisms of Innate Neuroprotection</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (138 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">As clinical trials of pharmacological neuroprotective strategies in stroke have been disappointing, attention has turned to the brain's own endogenous strategies for neuroprotection. Two endogenous mechanisms have been recently characterized, ischemic preconditioning and ischemic postconditioning. In the present topic newly characterized mechanisms involved in preconditioning- and postconditioning- neuroprotection will be discussed. The understanding of the mechanisms involved in the neuroprotective pathways induced by preconditioning and postconditioning will be clinically relevant for identifying new druggable target for neurodegenerative disorder therapy. Furthermore, the importance of these neuroprotective strategies resides in that it might be easily translatable into clinical practice. Therefore, the data presented here will highlight the capacity of ischemic preconditioning and postconditioning to be of benefit to humans.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Neuroprotection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">postconditioning</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NCX</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Stroke</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">seizure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">miRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Alzheimer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">preconditioning</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88919-929-0</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:52:27 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2017-09-30 19:47:25 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338302700004498&Force_direct=true</subfield><subfield code="Z">5338302700004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338302700004498</subfield></datafield></record></collection> |